Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans

Infect Immun. 2002 Nov;70(11):6471-4. doi: 10.1128/IAI.70.11.6471-6474.2002.

Abstract

Intravenous administration to volunteers of an emulsion of medium-chain lipids, but not of an emulsion of pure long-chain lipids or a placebo, increased the growth of Candida albicans in serum and modulated Candida-induced cytokine production by mononuclear cells in a way suggesting that medium-chain, but not long-chain, triglycerides increase the risk for infections by Candida.

Publication types

  • Clinical Trial

MeSH terms

  • Candida albicans / growth & development
  • Candidiasis / etiology*
  • Fat Emulsions, Intravenous / adverse effects*
  • Humans
  • Infusions, Intravenous
  • Interferon-gamma / biosynthesis
  • Neutrophils / immunology
  • Triglycerides / administration & dosage
  • Triglycerides / adverse effects*

Substances

  • Fat Emulsions, Intravenous
  • Triglycerides
  • Interferon-gamma